Abstract
Gas signaling molecules, including carbon monoxide (CO), nitric oxide (NO), and hydrogen sulfide (H2S), have been shown to have cancer therapeutic potential, pointing to a new direction for cancer treatment. In recent years, a series of studies have confirmed that hydrogen (H2), a weakly reductive gas, also has therapeutic effects on various cancers and can mitigate oxidative stress caused by radiation and chemotherapy, reducing tissue damage and immunosuppression to improve prognosis. Meanwhile, H2 also has immunomodulatory effects, inhibiting T cell exhaustion and enhancing T cell anti-tumor function. It is worth noting that human intestinal flora can produce large amounts of H2 daily, which becomes a natural barrier to maintaining the body’s resistance to diseases such as tumors. Although the potential anti-tumor mechanisms of H2 are still to be investigated, previous studies have shown that H2 can selectively scavenge highly toxic reactive oxygen species (ROS) and inhibit various ROS-dependent signaling pathways in cancer cells, thus inhibiting cancer cell proliferation and metastasis. The ROS scavenging ability of H2 may also be the underlying mechanism of its immunomodulatory function. In this paper, we review the significance of H2 produced by intestinal flora on the immune homeostasis of the body, the role of H2 in cancer therapy and the underlying mechanisms, and the specific application of H2 to provide new ideas for the comprehensive treatment of cancer patients.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
According to recent World Health Organization (WHO) statistics (Sung et al. 2021; Wen et al. 2021; Siegel et al. 2020), cancers are the first or second leading cause of death in 112 of 183 countries worldwide, posing a severe threat to human health, and overall the global burden of cancer morbidity and mortality will continue to increase (Wen et al. 2021). Currently, surgery is still the primary method to treat solid cancers, combined with radiotherapy and chemotherapy, including a variety of cytotoxic drugs, tyrosine kinase inhibitors, in addition to immunotherapy such as immune checkpoint inhibitors, such as anti-programmed cell death 1 (PD-1), anti-programmed cell death ligand 1 (PD-L1), and anti-cytotoxic T lymphocyte-associated protein 4 (CTLA-4) antibodies (Xu et al. 2018). However, these approaches often fail to achieve satisfactory clinical results in cancer treatment (Vasan et al. 2019).
Gas signaling molecules are small molecule gases that affect cellular biology by regulating signal transduction, such as nitric oxide (NO) (Tien Vo et al. 2021), carbon monoxide (CO) (Oliveira et al. 2018), and hydrogen sulfide (H2S) (Flannigan and Wallace 2015). Studies have confirmed that multiple gas signaling molecules have anti-tumor properties and can be used directly or as products of specific agents for anti-tumor treatment.
Recently, studies have proved H2 to be another gas signaling molecule showing intriguing potential in cancer therapy (Wu et al. 2019; Li et al. 2019). Since 1975, when Dole et al. (1975) found that high concentrations of H2 could cure squamous cell carcinoma implanted in the skin of mice, numerous laboratory and clinical studies have confirmed that H2 is effective against various cancers (Wu et al. 2019; Li et al. 2019; Hirano et al. 2021a). Furthermore, H2 effectively synergizes with anti-tumor therapies such as radiotherapy and cytotoxic drugs (Runtuwene et al. 2015; Meng et al. 2015; Hirano et al. 2021b), reducing damage to body (Yang et al. 2012) and improving patient prognosis.
In a landmark study in 2007 (Ohsawa et al. 2007), Oshawa et al. found that H2 could selectively neutralize highly toxic reactive oxygen species (ROS) (hydroxyl radicals, ·OH, and peroxynitrite, ONOO–) without affecting other physiological ROS. The ROS-scavenging capacity of H2 is likely to be a critical underlying mechanism for its anti-tumor activity. However, the underlying mechanism of hydrogen in tumor therapy is controversial due to the lack of specific signaling receptors that other gas signaling molecules have. In this review, we first discuss the importance of H2 metabolism by the intestinal flora under physiological conditions for the homeostasis of the human internal environment. Then we discuss the mechanism of H2 anti-tumor through its unique antioxidant capacity to provide a comprehensive account of the mechanism of hydrogen action in tumor therapy. At last, we discussed the specific role of different application modalities of H2 and explored the prospect of hydrogen application in clinical tumor therapy.
Anti-tumor barrier: H2 produced by intestinal flora
Under normal physiological conditions, adult gut microbiota can produce large amounts of H2 daily (Mego et al. 2017; Carbonero et al. 2012), and this H2 can regulate the balance of intestinal flora and their metabolites, which are essential for immune homeostasis in humans. It demonstrates that H2 is the body’s natural anti-tumor barrier and provides new strategies for its clinical use.
H2 metabolism in intestine
The intestinal hydrogenogenic bacteria mainly use various indigestible carbohydrates as substrates for anaerobic oxidative energy production, including starch, cellulose, and some sugars (Jiang et al. 2020). This process can produce large amounts of H2, which is quickly absorbed and used by hydrogenotrophic bacteria. H2 participates in this series of reactions as an electron transporter and is a vital energy substance for the survival and proliferation of intestinal flora (Carbonero et al. 2012; Greening et al. 2016). Most of the H2 not used by the flora is excreted through respiration and the anus, while the rest can enter the circulation or penetrate the intestinal lumen and peritoneum into the peritoneal cavity (Nishimura et al. 2013).
The hydrogenotrophic bacteria mainly include reductive acetate-producing bacteria, sulfate-reducing bacteria (SRB), and methanogenic bacteria, which, respectively, oxidize H2 to acetate, H2S, and CH4 (Carbonero et al. 2012). The H2 concentration in the intestine not only passively responds to the balance of these florae but also controls the balance of hydrogenogenic and hydrogenotrophic flora by partial pressure of hydrogen (pH2) (Carbonero et al. 2012). For example, a study found (Ge et al. 2022) that hydrogen-rich water (HRW) supplementation significantly inhibited the expansion of opportunistic pathogenic E. coli and increased intestinal integrity in mice with colitis by modulating intestinal flora H2 metabolism.
Studies have confirmed that intestinal flora disorders can affect the occurrence and development of cancers in multiple organs throughout the body, including colorectal cancers (Song et al. 2020; Helmink et al. 2019). Although hydrogenogenic and hydrogenotrophic microbes cover most intestinal flora, the specific morphology and metabolism of the flora contained in them vary greatly and lack proper taxonomy, so there are few articles directly studying the relationship between intestinal H2 metabolizing and cancers. Several studies investigated the genomic and meta-genomic distribution of hydrogenases, the reversible enzymes that catalyze the oxidation and evolution of H2, to understand more about the contribution of H2 metabolism to gut ecosystems (Greening et al. 2016; Peters et al. 2015; Suzuki et al. 2018). According to the binding metal cofactor, Greening et al. identified 4 groups (22 subgroups) of [NiFe]-hydrogenases, 3 groups (6 isoforms) of [FeFe]-hydrogenases, and a small group of [Fe]-hydrogenases (Greening et al. 2016). This hydrogenase diversity supports crucial metabolic pathways of intestinal flora, such as H2-based respiration, fermentation, and carbon fixation processes, reflecting the scope of H2 metabolism in sustaining the growth and survival of microorganisms. Until now, the authors indicated that most related studies focus on only a few branches of the hydrogenase phylogenetic tree and a small fraction of organisms within the universal tree of microorganisms.
However, it is easy to find that H2 produced by intestinal flora can participate in the regulation of various flora metabolites related to carcinogenesis (Ge et al. 2022; Fan and Pedersen 2021; Kalantar-Zadeh et al. 2019), such as H2 can scavenge ROS and promote the production of short-chain fatty acids (SCFAs). For example, a study demonstrated that oral administration of HRW in mice could promote the production of SCFAs in cecal contents and circulation by modulating the composition of intestinal flora (Higashimura et al. 2018).
In contrast, high SRB and sulfur protein diets are associated with the development of colon cancer (Nguyen et al. 2020; Lee et al. 2022), which can disrupt cytochrome oxidase, inhibit butyrate utilization, block mucus synthesis, and cause DNA methylation through the production of H2S. In addition, excessive H2S production by intestinal flora plays an important role in the carcinogenesis and development of intestinal tumors (Ngowi et al. 2021; Attene-Ramos et al. 2010; Dalal et al. 2021). Paradoxically, various sulfur-containing diets have long-proven anti-tumor properties, such as garlic and cruciferous vegetables (Rose et al. 2021; Abbaoui et al. 2018). We think part of the reason is the balance of SRB with other hydrogen-metabolizing flora in the lumen in those different dietary settings. Moreover, the balance of H2 and H2S metabolized by SRB may be the underlying mechanism (Fig. 1).
H2 produced by intestinal flora can maitain homeostasis
Intestinal H2 metabolizing is not only fundamental to gut health but also crucial for redox balance and immune homeostasis in multiple organs (Fig. 2).
Studies have shown that H2 maintains the integrity of the intestinal barrier, reduces intestinal inflammation and damage in rat (Wu et al. 2017), and protects ischemia–reperfusion of the brain, lung, liver, and other organs (Dong et al. 2018; Fang et al. 2018; Sano et al. 2018; Ishikawa et al. 2018). H2 is also fundamental to pelvic health and guarantees organ function (Zhang et al. 2021). In male and female organs, such as testes and ovaries, after damage leading to dysfunction, H2 supplementation can effectively reduce oxidative stress and promote recovery of organ function. Although many studies have focused on exogenous H2 supplementation, H2 production in the gut is as effective as H2 inhalation and H2 oral HRW in raising H2 levels in the body. For example, the administration of fructose promotes an 11-fold increase in intraperitoneal H2 concentration and a significant increase in H2 in the blood system (Nishimura et al. 2013).
SCFA is an essential source of energy for intestinal epithelium and multiple immune cells (Yip et al. 2021), as well as a communication material between the gut–lung axis and gut–brain axis (Fulling et al. 2019) that sustains immune homeostasis throughout the body. H2, produced by gut bacteria, is the substrate for SCFAs synthesis and promotes the synthesis of SCFAs. It was found that HRW can increase propionate, butyric acid, and total SCFAs in the gut by regulating gut flora to treat brain diseases such as Parkinsonism (Bordoni et al. 2019; Ostojic 2021). Diets or medications that promote H2 production in the gut, such as high-fiber diets and lactose, also promote the production of SCFAs (Chen and Vitetta 2018; Zhai et al. 2018). A study in mice (Ge et al. 2022) suggested that HRW can strengthen the intestinal barrier by regulating specific mucositis-related mucolytic bacteria through the H2–H2 metabolic microbiota–SCFAs axis, ensuring the body’s internal environment.
Anti-tumor effect of H2 and the underlying mechanism
H2 anti-tumor and synergistic anti-tumor effects
Starting with the research by Dole et al. (1975) that high concentrations of H2 cured squamous carcinomas grown on mouse skin, several studies have confirmed the anti-tumor effects of H2. Wang et al. (2018) reported that in cells and mice, H2 inhibited the proliferation, metastasis, and invasion of lung cancer cells and reduced lung cancer volume by inhibiting chromosome stabilization protein 3 (SMC3). A clinical study by Akagi and Baba (2019) found that inhalation of H2 for 3 h daily significantly prolonged progression-free survival and overall survival in stage IV colon and rectal patients. A study of inhaled H2 in 82 cases of intermediate to advanced cancer treatment also confirmed the anti-tumor effect of H2 (Chen et al. 2020).
Chemotherapy and radiotherapy are still the main strategies for cancer treatment. However, these treatment regimens lead to significant oxidative stress and inflammation, causing damage to human organs, and H2 can be used as an adjuvant regimen to suppress these adverse effects due to its cytoprotective properties, such as antioxidant and anti-inflammatory (Meng et al. 2015). Runtuwene et al. (2015) gave HRW drinking to colorectal cancer-bearing mice treated with 5-fluorouracil intravenously. They found that HRW enhanced apoptosis of cancer cells by causing significant increases in the expression of p-AMPK, apoptosis-inducing factor (AIF), and caspase-3 in non-cancer cells and prolonging the life span of cancer-bearing animals. Cisplatin causes the accumulation of ROS in humans, decreases glutathione activity, and causes increased oxidative stress, while H2 reverses cisplatin-induced oxidative stress in the body and restores antioxidant enzyme activity (Kikkawa et al. 2014). In addition, H2 reduces cisplatin’s nephrotoxicity without affecting its anti-tumor effect and enhances animal survival in mice experiments. Oral administration of HRW (0.55–0.65 mM, 1.5–2.0 L per day) to patients with hepatocellular carcinoma receiving radiotherapy suppressed the level of oxidative stress in patients and improved their quality of life without affecting the effect of radiotherapy (Nakashima-Kamimura et al. 2009). Some studies reported that the administration of inhaled H2 during radiotherapy treatment reduced the damage to the hematological and immune systems (Hirano et al. 2021b; Yang et al. 2012) and alleviated the growth of radiotherapy-induced thymic lymphoma (Zhao et al. 2011).
Although a series of studies have confirmed the anti-tumor effects of H2, it is indispensable to understand the underlying mechanisms in depth to support further H2 application in clinic. H2 has an extensive range of physiological effects, including anti-oxidative stress, anti-inflammation, and regulation of apoptosis (Li et al. 2019). Furthermore, some studies proved that H2 has an anti-tumor effect by indirectly regulating gene expression (Hirano et al. 2021a). Through these studies, we believe that the ability of H2 to selectively scavenge highly toxic ROS may be the core and fundamental mechanism of its anti-tumor effects, so this paper mainly focuses on this point of discussion.
H2 anti-tumor activity through anti-oxidative stress
Intracellular ROS are mainly derived from catalytic reactions regulated by oxidative phosphorylation (OXPHOS) of the mitochondrial respiratory chain and NADPH oxidase (NOX) in the cytoplasm (Holmstrom and Finkel 2014). On the one hand, ROS are extremely oxidative and destructive to biomolecules proteins, phospholipids, and nucleic acids; on the other hand, ROS are key intracellular signaling molecules that can affect cell proliferation and differentiation by regulating various signaling pathways, such as NF-κB and Akt/mTOR (Cheung and Vousden 2022; Zhang et al. 2016). Under normal physiological conditions, the complete system of antioxidant enzymes in the body keeps the ROS concentration in a precise dynamic balance, including superoxide dismutase (SOD), which converts \({\text{O}}_2^{\cdot -}\) to H2O2, then glutathione peroxidase (GPx) and catalase (CAT) convert H2O2 to water (Cheung and Vousden 2022; Meng et al. 2021). However, the body lacks specific scavenging systems for ·OH and ONOO–, and these two ROS are highly cytotoxic and have damaging effects on almost all macromolecules (proteins, nucleic acids, lipids), which can lead to DNA double-strand structure disruption and base pairing damage (Cheung and Vousden 2022; Jena 2012), resulting in carcinogenesis.
Activation of oncogenes altered mitochondrial function (Ismail et al. 2019), and hypoxia collectively contribute to increased ROS production in cancer cells. Unfortunately, the antioxidant enzyme system in tumor cells is often unable to counteract overgenerated ROS, resulting in a high ROS state in the tumor microenvironment (Cheung and Vousden 2022; Zhang et al. 2016; Liao et al. 2019; Hornsveld and Dansen 2016). Indeed, cancer cells can not only adapt to a moderately high ROS state but also take advantage of ROS to drive the malignant phenotype. This happens because ROS can enhance NF-κB, Akt/mTOR, Wnt/β-catenin pathways, and oncogenes such as Ras, Bcr/Abl, and c-Myc expression (Cheung and Vousden 2022; Liao et al. 2019; Hornsveld and Dansen 2016; Wojtovich et al. 2019), which maintain high-intensity metabolism and proliferation of tumor cells. Furthermore, ROS-dependent signaling pathways can promote cancer invasion and metastasis (Cheung and Vousden 2022; Liao et al. 2019). However, some reports (Cheung and Vousden 2022; Hornsveld and Dansen 2016) suggest that persistently elevated ROS in the cancer microenvironment can limit further cancer progression after reaching a certain level. Thus, non-selective antioxidant therapy in cancer treatment may lead to further cancer progression (Meng et al. 2021; Sayin et al. 2014; Chandel and Tuveson 2014). H2 selectively removes strongly oxidizing without affecting other ROS, making it an ideal therapy antioxidant.
On the one hand, H2 can inhibit the damage of cellular DNA by ·OH and ONOO– to prevent cancer development; on the other hand, H2 can remove ROS from cancer cells and inhibit multiple ROS-dependent metabolic signaling pathways to suppress cancer development. Studies have confirmed that H2 can effectively reduce oxidative stress caused by various pathological conditions, including cancers, and promote the restoration of redox homeostasis (Adzavon et al. 2022; Shi et al. 2016; Kawai et al. 2012).
H2 can also elevate the expression of some antioxidant enzymes that play a crucial role in regulating redox homeostasis in cancer cells (Li et al. 2019; Slezak et al. 2021), which exerts anti-tumor effects. Some non-cancer studies proved that H2 treatment induced a significant increase in the expression of intracellular SOD, GPx, CAT (Zhou et al. 2019), and heme oxygenase-1 (HO-1) (Fang et al. 2018; Iketani et al. 2017), enhancing their potential to eliminate ROS.
H2’s ability to modulate various signaling pathways is another essential mechanism for its antioxidant action, such as Nrf2/ARE and p38/MAPK (Fang et al. 2018; Slezak et al. 2021; Xie et al. 2020). A series of subsequent studies have found that H2 also maintains redox balance in the body by activating the Keap1-Nrf2-ARE, and Nrf2-HO-1 pathways (Slezak et al. 2021; Xie et al. 2020; Yu et al. 2019; Chen et al. 2015), which exerts immunomodulatory, anti-inflammatory, and cancer pro-apoptotic effects. Wang et al. (2018) found that H2 inhibited ROS expression and increased SOD, IL-1β, IL-8, IL-13, and tumor necrosis factor-α (TNF-α) expression in lung tissue of cancer-bearing mice. (Fig. 3).
The immunoprotective function of H2
Many clinical trials have confirmed the role of H2 in modulating cancer immunity. A 2018 clinical study involving 55 stage IV colon cancer patients showed that inhalation of H2 reduced PD-1 expression on CD8+ T cells in the patient’s peripheral blood, reduced CD8+ T cell depletion, and improved prognosis (Akagi and Baba 2019). In a clinically advanced small cell lung cancer study, continuous H2 inhalation for 2 weeks reversed the suppressed intrinsic and adaptive immune systems in patients’ peripheral blood, reduced depleted CD8+ T cells, and restored functional CD4+, CD8+ T cells, and natural killer cell ratios to normal levels (Chen et al. 2020). Although few studies investigate the underlying mechanisms, the ability to selectively clear toxic ROS and protect T cell mitochondria may be the core mechanism of H2’s immune protection function.
After T cell receptor (TCR) activation by antigen-presenting cancer antigens, downstream signal transduction enhances mitochondrial metabolism, and ROS, the apparent byproducts of mitochondrial metabolism, are significant molecules that regulate multiple core pathways involved in T cell metabolic recombination (Franchina et al. 2018; Franco et al. 2020). However, as previously noted, overgrowing cancer cells can cause elevated ROS in the cancer microenvironment, and mitochondria produce high ROS when T cells are activated, in addition to increased ROS in T cells due to factors such as hypoxia (Scharping et al. 2021), which results in tumor-infiltrating lymphocytes (TILs) facing a far higher physiological state of ROS when activated (Franco et al. 2020). Sustained high ROS levels disrupt T cell mitochondria, inhibit T cell activation and lead to T cell dysfunction by deflecting T cell metabolic restructuring (Laura 2012; Scharping et al. 2016), and promote PD-1 expression to induce apoptosis (Najjar et al. 2019) (Fig. 4). H2, on the other hand, combats oxidative stress in various disease conditions and restores redox balance in the body’s environment by regulating the NADH/NADPH pathway (Adzavon et al. 2022; Tao et al. 2019), thereby safeguarding T cell activation and preventing apoptosis. Moreover, in this condition, compared with routine anti-tumor medicine, the high permeability of H2 grants it to easily penetrate inside the tumor, even into structures such as the mitochondria of the TILs.
Since the mitochondrial respiratory chain is the primary source of ROS production in cells, high local concentrations of ROS can lead to mutations of mitochondrial DNA and direct disruption of mitochondrial dynamics, ultimately leading to mitochondrial metabolic dysfunction (Deng et al. 2020) and apoptosis of T cells(Scharping et al. 2021). The study shows that TILs in renal cell carcinoma contain hyperpolarized, fragmented mitochondria producing significant ROS (Siska et al. 2017). Akagi et al. found in clinical studies of lung cancer patients (Akagi and Baba 2019, 2020) that inhalation of H2 enhances the mitochondrial function of CD8+ T cells and decreases PD-1 expression in the patient’s peripheral blood, suggesting that H2 may act by regulating peroxisome proliferators activate receptor-γ coactivator-1α (PGC-1α). Mo et al. (2019) suggested that in vitro H2 can enter mitochondria to neutralize toxic ROS, attenuate mitochondrial oxidative stress damage, protect Na+/Ka+ ATP pumps, enhance Bcl-2 expression, inhibit voltage-dependent anion channel 1 (VDAC1) expression and opening, protect mitochondrial membranes, and also inhibit the release of apoptotic factors such as caspase 9.
Application of H2
Exogenous H2 administration
The conventional ways of exogenous administration of H2 are inhalation, oral HRW, injection of saline containing H2, and external use, such as eye drops and HRW baths (Fig. 5). Some reviews have compared the rates of H2 concentration increase in different body organs caused by different H2 application methods and their therapeutic effects (Li et al. 2019; Hirano et al. 2021a), and we will not present them here individually. However, we cannot simply correlate the role of different H2 application methods in disease treatment with H2 concentrations in the circulatory and respiratory systems—for example, the unique role of HRW in regulating intestinal flora and energy metabolism.
Some studies suggest that HRW can regulate intestinal flora and contribute to restoring and maintaining the intestinal flora’s homeostasis (Higashimura et al. 2018; Kajiyama et al. 2008). In 2018, Japanese scholars (Higashimura et al. 2018) found that oral administration of HRW for 4 weeks improves the distribution of flora in the colon, increases SCFA production, and decreases plasma cholesterol concentration. Xiao et al. (2018) found that HRW could affect intestinal flora by regulating the expression of MyD88, thereby reducing the injury from abdominal radiotherapy and increasing survival and body weight after radiotherapy in mice. HRW has also interacted with diet to enhance and prolong hepatic H2 accumulation (Kamimura et al. 2011), lower blood lipids and glucose, and promote the direct secretion of brain intestinal peptides from intestinal epithelial cells (McCarty 2015). In one article (Ito et al. 2012), HRW prevented the development of 6-hydroxydopamine-induced Parkinson’s disease in mice, whereas continuous H2 inhalation and oral lactulose were less effective. Although the article did not explore the underlying mechanisms of this phenomenon, the unique physiological effects of HRW, such as the regulation of intestinal flora, may contribute to it.
Some scientists have designed nanoparticles that can release large amounts of H2 at cancer sites (Wu et al. 2019, 2021; Sun et al. 2020), providing the possibility of precise local production of sustained high concentrations of H2 to enhance the anti-tumor effect, and the combined application of nanotechnology and H2 may be an important direction for future precision cancer therapy. For example, Zhang et al. constructed covalently loaded liposomes with semiconductor polymers-Pdots as catalysts (Zhang et al. 2019), a “nanoscale H2 factor” containing reactants, intermediates, and byproducts, which can continuously produce H2 at the site by laser stimulation and effectively reduce cancer growth in mice. Sun et al. designed a laser-triggered H2 release nanoparticle to enhance the chemotherapeutic effect of mouse bladder cancer and reduce the toxic response of chemotherapeutic drugs (Sun et al. 2020). Wu et al. constructed Au-TiO2@ZnS nanoparticles that can release H2 triggered by in vitro X-ray under the guidance of in vitro photoacoustic imaging, achieving an excellent therapeutic effect and mild inflammatory response in combination with radiotherapy for in situ liver cancer in mice (Wu et al. 2021).
Regulating intestinal flora production of H2
In addition to the exogenous H2 supplementation mentioned above, supplementation with high fiber, indigestible starches, and sugars can also increase intestinal H2 production through intestinal flora, which is the most suitable and economical treatment for daily life (Fig. 5).
Lactulose is a disaccharide that cannot be absorbed by the body and can promote large amounts of H2 production by intestinal flora, thus effectively increasing the concentration of H2 in the human abdominal cavity and blood. Studies have confirmed that lactulose can relieve inflammation and injury in multiple organs such as the intestine and brain by promoting intestinal H2 production, such as mitigating ulcerative colitis caused by the carcinogenic substance dextran sodium sulfate (DSS) (Zhai et al. 2013; Chen et al. 2013). Perlamutrov et al. (2016) found that lactulose can treat dermatitis by stimulating H2 and SCFA production. Studies have confirmed that oral administration of lactulose or dietary fiber containing indigestible starch and dietary fiber can regulate intestinal flora (Jiang et al. 2020; Trompette et al. 2014), balance the intestinal environment, and have therapeutic effects on multi-system diseases such as chronic obstructive pulmonary disease (COPD) and neurological disorders (Vaughan et al. 2019; Kong et al. 2021). Although some researchers have attributed much of the clinical effects of lactulose and fibrates to specific intestinal flora and SCFAs, H2 may be an overlooked link in these experiments (Kalantar-Zadeh et al. 2019; Desai et al. 2016). Similar drugs, fructans, and inulin, also have anti-inflammatory and metabolic-modulating effects by promoting intestinal H2 production (Nishimura et al. 2013).
Perioperative dietary management has profound meaning for the long-term prognosis of cancer patients. To ensure the energy requirements and enhance the immunity of cancer patients, some researchers have proposed the concept of an immunonutrition diet (Adiamah et al. 2021; Svetikiene et al. 2021; Prieto et al. 2017), including glutamine, arginine, sulfur-containing amino acids, and polyunsaturated fatty acids. However, such a high-protein, high-fat diet may cause elevated blood glucose and lipids and metabolic disorders in patients on the one hand, and poor dietary choice may cause adverse emotions in patients on the other hand. As mentioned earlier, oral HRW has a good energy regulation function, which can improve the liver energy metabolism of the body, lower blood lipid glucose, and reduce the side effects of a high-fat diet (Qiu et al. 2020). In contrast, some studies show that fiber and indigestible starch diets have anti-inflammatory and anti-tumor effects (Jiang et al. 2020; Trompette et al. 2014; Desai et al. 2016). Therefore, a fiber-rich diet or oral HRW combined with an immunonutritional diet may be a more suitable dietary strategy for cancer patients in the perioperative period.
H2 in perioperative applications
Clinically, tumors often need surgical treatment, so they inevitably face multiple perioperative stress factors such as trauma, anesthesia, and mental stress. Rapidly elevated oxidative stress can lead to an imbalance of internal environmental homeostasis and immune system suppression in tumor patients while promoting tumor recurrence and metastasis (Hsiao et al. 2021; Matzner et al. 2020; Seckler et al. 2020). H2 has physiological effects of antioxidant, anti-inflammatory, and immune modulation, which can effectively antagonize these unfavorable factors (Sano et al. 2018) (Fig. 6).
In addition, H2 can effectively alleviate ischemia–reperfusion injury in multiple organs (Dong et al. 2018; Xie et al. 2020; Fu and Zhang 2022). For example, in a randomized controlled clinical trial of 26 patients (Ono et al. 2017), Ono et al. found that 3% H2 inhaled twice daily for 1 h significantly improved vital signs, stroke scale scores, physiotherapy index, and 2-week brain MRI in stroke patients compared with conventional treatment.
Postoperative cognitive dysfunction (POCD) is a postoperative complication in patients undergoing clinical procedures and is particularly prevalent in older patients. Currently, the recognized etiology of POCD is neuroinflammation caused by the combined effects of anesthetics and surgery-induced systemic inflammation (Lai et al. 2021). H2 supplementation alleviates symptoms of central nervous system disorders such as Parkinson’s disease and autism by redressing intestinal flora imbalance (Suzuki et al. 2018; Kong et al. 2021; Doifode et al. 2021). Li et al. (2010) reported that intraperitoneal injection of hydrogen-rich saline effectively alleviated central nervous system inflammation and oxidative stress and reduced cognitive impairment in mice. Therefore, some researchers have stated that H2 can be used for neuroprotection in perioperative patients (Wang et al. 2020) (Fig. 6).
Conclusion and perspectives
The H2 produced by intestinal flora is a natural antioxidant in the body’s internal environment, which can regulate oxidative stress caused by various reasons in the body’s internal environment and become a natural barrier against carcinogenesis and development. H2 is also a substrate for the production of SCFAs through the intestinal flora, essential substances for maintaining the stability of the body’s immune system and affecting the gut–brain axis and the gut–lung axis. However, there may be more potential mechanisms for why H2 has such a wide range of effects. For example, HRW can promote the production of ghrelin (McCarty 2015), which is crucial in regulating food intake and energy homeostasis. Therefore, whether H2 can affect the body’s immune system by regulating the secretion of other flora metabolites or affecting energy metabolism by other gastrointestinal hormones needs further investigation.
Intestinal flora and cancers have long attracted widespread medical attention, and scholars in several countries have actively studied the relationship between genomics and metabolomics of intestinal flora and cancers (Song et al. 2020; Fulling et al. 2019; Erny and Prinz 2020). In those studies, researchers suggest that sulfate-reducing bacteria are related to colorectal cancer (Nguyen et al. 2020). More analysis of a large sample of intestinal flora genomics from the perspective of H2 metabolizing flora and insight into the association between intestinal flora H2 metabolism and cancer may be able to find new drug targets and guide the subsequent application of H2 in cancer therapy. For example, some researchers explored the significance of the H2 metabolism of microbiota through genomic and meta-genomic surveys of the distribution of hydrogenase subtypes (Greening et al. 2016; Peters et al. 2015).
Studies have shown that H2 inhalation for about 2 weeks can restore the body’s redox balance and enhance immune cells’ function in the peripheral blood of cancer patients, which indicates that H2 has a protective effect on the overall immune system of the body. However, in-depth studies on the specific effects of H2 on TILs in the cancer microenvironment and its potential mechanisms are still lacking. However, according to some studies (Akagi and Baba 2020), H2 can protect the mitochondria of TILs by scavenging ROS, preventing the differentiation of TIL toward the end-stage phenotype, and acting as a qualified adjuvant immunotherapeutic agent. Therefore, its synergistic therapeutic effects with immune checkpoint blockers are yet to be studied.
Furthermore, some studies suggested HRW can regulate the energy metabolism of hepatocytes and adipocytes (Kajiyama et al. 2008; Kamimura et al. 2011; Acker et al. 2021; Iio et al. 2013). Although it remains to be investigated whether H2 can play a role in energy metabolism in cancer cells or immune cells similar to that in hepatocytes and adipocytes, those researches indicated that HRW may exert a more comprehensive potential in anti-tumor immunotherapy by regulating immunometabolism.
There is often cross-talk between gas signaling molecules. For example, H2S and NO can regulate each other’s production and enhance each other’s anti-tumor effects (Jing et al. 2021). Moreover, it is not difficult to find the intrinsic connection between H2 and other gas signaling molecules, such as sulfate-reducing bacteria can metabolize H2 to produce H2S, which are in some delicate balance in the intestine. H2 can regulate CO production through HO-1 (Yu et al. 2019), and H2 can inhibit inducible nitric oxide synthase (iNOS) and enhance the expression of endothelial nitric oxide synthase (eNOS) (Slezak et al. 2021). Combining H2 with other gas signaling molecules may be the development direction of H2 for cancer treatment, and some studies have suggested this idea in nanotechnology (Jing et al. 2021).
Data availability
No datasets were generated or analysed during the current study.
Abbreviations
- AIF:
-
Apoptosis-inducing factor
- AMPK:
-
Adenosine monophosphate activated protein kinase
- ARE:
-
Antioxidant response element
- CAT:
-
Catalase
- CH4 :
-
Methane
- CO:
-
Nitric oxide
- COPD:
-
Chronic obstructive pulmonary disease
- CTLA4:
-
Cytotoxic T lymphocyte-associated protein 4
- DNA:
-
Deoxyribonucleic acid
- DSS:
-
Dextran sodium sulfate
- FGF21:
-
Fibroblast growth factor
- GHS-R1a:
-
Secretion stimulating receptor for endogenous growth hormone-1a
- GPx:
-
Glutathione peroxidase
- GSM:
-
Gas signaling molecules
- H2 :
-
Hydrogen
- H2O2 :
-
Hydrogen peroxide
- H2S:
-
Hydrogen sulfide
- HO-1:
-
Heme oxygenase-1
- HRW:
-
Hydrogen rich water
- IL:
-
Interleukin
- iNOS:
-
Inducible nitric oxide synthase
- Keap1:
-
Kelch-like ECH-associated protein 1
- mTOR:
-
Mammalian target of rapamycin
- NADH:
-
Nicotinamide adenine dinucleotide
- NADPH:
-
Nicotinamide adenine dinucleotide phosphate
- NF-kb:
-
Nuclear transcription factor kappa b
- NO:
-
Nitric oxide
- NOX:
-
NADPH oxidase
- Nrf2:
-
Nuclear factor erythroid-2-related factor 2
- OXPHOS:
-
Oxidative phosphorylation
- PD-1:
-
Programmed cell death 1
- PD-L1:
-
Programmed cell death ligand 1
- PGC-1α:
-
Peroxisome proliferators activate receptor-γ coactivator -1α
- pH2 :
-
Partial pressure of hydrogen
- POCD:
-
Postoperative cognitive dysfunction
- ROS:
-
Reactive oxygen species
- SCFA:
-
Short-chain fatty acid
- SMC3:
-
Chromosome stabilization protein 3
- SOD:
-
Superoxide dismutase
- SRB:
-
Sulfate-reducing bacteria
- TCR:
-
T cell receptor
- TILs:
-
Tumor-infiltrating T cells
- TNF-α:
-
Tumor necrosis factor-α
- VDAC1:
-
Voltage-dependent anion channel 1
- WHO:
-
World Health Organization
References
Abbaoui B, Lucas CR, Riedl KM, Clinton SK, Mortazavi A (2018) Cruciferous vegetables, isothiocyanates, and bladder cancer prevention. Mol Nutr Food Res 62(18):e1800079
Adiamah A, Rollins KE, Kapeleris A, Welch NT, Iftikhar SY, Allison SP, Lobo DN (2021) Postoperative arginine-enriched immune modulating nutrition: long-term survival results from a randomised clinical trial in patients with oesophagogastric and pancreaticobiliary cancer. Clin Nutr 40(11):5482–5485
Adzavon YM, Xie F, Yi Y, Jiang X, Zhang X, He J, Zhao P, Liu M, Ma S, Ma X (2022) Long-term and daily use of molecular hydrogen induces reprogramming of liver metabolism in rats by modulating NADP/NADPH redox pathways. Sci Rep 12(1):3904
Akagi J, Baba H (2019) Hydrogen gas restores exhausted CD8+ T cells in patients with advanced colorectal cancer to improve prognosis. Oncol Rep 41(1):301–311
Akagi J, Baba H (2020) Hydrogen gas activates coenzyme Q10 to restore exhausted CD8(+) T cells, especially PD-1(+)Tim3(+)terminal CD8(+) T cells, leading to better nivolumab outcomes in patients with lung cancer. Oncol Lett 20(5):258
Attene-Ramos MS, Nava GM, Muellner MG, Wagner ED, Plewa MJ, Gaskins HR (2010) DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 Int cells. Environ Mol Mutagen 51(4):304–314
Bordoni L, Gabbianelli R, Fedeli D, Fiorini D, Bergheim I, Jin CJ, Marinelli L, Di Stefano A, Nasuti C (2019) Positive effect of an electrolyzed reduced water on gut permeability, fecal microbiota and liver in an animal model of Parkinson’s disease. PLoS ONE 14(10):e0223238
Carbonero F, Benefiel AC, Gaskins HR (2012) Contributions of the microbial hydrogen economy to colonic homeostasis. Nat Rev Gastroenterol Hepatol 9(9):504–518
Chandel NS, Tuveson DA (2014) The promise and perils of antioxidants for cancer patients. N Engl J Med 371(2):177–178
Chen J, Vitetta L (2018) Inflammation-modulating effect of butyrate in the prevention of colon cancer by dietary fiber. Clin Colorectal Cancer 17(3):e541–e544
Chen X, Zhai X, Shi J, Liu WW, Tao H, Sun X, Kang Z (2013) Lactulose mediates suppression of dextran sodium sulfate-induced colon inflammation by increasing hydrogen production. Dig Dis Sci 58(6):1560–1568
Chen H, Xie K, Han H, Li Y, Liu L, Yang T, Yu Y (2015) Molecular hydrogen protects mice against polymicrobial sepsis by ameliorating endothelial dysfunction via an Nrf2/HO-1 signaling pathway. Int Immunopharmacol 28(1):643–654
Chen JB, Kong XF, Qian W, Mu F, Lu TY, Lu YY, Xu KC (2020) Two weeks of hydrogen inhalation can significantly reverse adaptive and innate immune system senescence patients with advanced non-small cell lung cancer: a self-controlled study. Med Gas Res 10(4):149–154
Cheung EC, Vousden KH (2022) The role of ROS in tumour development and progression. Nat Rev Cancer 22(5):280–297
Dalal N, Jalandra R, Bayal N, Yadav AK, Harshulika, Sharma M, Makharia GK, Kumar P, Singh R, Solanki PR, Kumar A (2021) Gut microbiota-derived metabolites in CRC progression and causation. J Cancer Res Clin Oncol 147(11):3141–3155
Deng H, Yang W, Zhou Z, Tian R, Lin L, Ma Y, Song J, Chen X (2020) Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death. Nat Commun 11(1):4951
Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, Pudlo NA, Kitamoto S, Terrapon N, Muller A, Young VB, Henrissat B, Wilmes P, Stappenbeck TS, Nunez G, Martens EC (2016) A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167(5):1339-1353.e21
Doifode T, Giridharan VV, Generoso JS, Bhatti G, Collodel A, Schulz PE, Forlenza OV, Barichello T (2021) The impact of the microbiota-gut-brain axis on Alzheimer’s disease pathophysiology. Pharmacol Res 164:105314
Dole M, Wilson FR, Fife WP (1975) Hyperbaric hydrogen therapy: a possible treatment for cancer. Science 190(4210):152–154
Dong A, Yu Y, Wang Y, Li C, Chen H, Bian Y, Zhang P, Zhao Y, Yu Y, Xie K (2018) Protective effects of hydrogen gas against sepsis-induced acute lung injury via regulation of mitochondrial function and dynamics. Int Immunopharmacol 65:366–372
Erny D, Prinz M (2020) How microbiota shape microglial phenotypes and epigenetics. Glia 68(8):1655–1672
Fan Y, Pedersen O (2021) Gut microbiota in human metabolic health and disease. Nat Rev Microbiol 19(1):55–71
Fang W, Wang G, Tang L, Su H, Chen H, Liao W, Xu J (2018) Hydrogen gas inhalation protects against cutaneous ischaemia/reperfusion injury in a mouse model of pressure ulcer. J Cell Mol Med 22(9):4243–4252
Flannigan KL, Wallace JL (2015) Hydrogen sulfide-based anti-inflammatory and chemopreventive therapies: an experimental approach. Curr Pharm Des 21(21):3012–3022
Franchina DG, Dostert C, Brenner D (2018) Reactive oxygen species: involvement in T cell signaling and metabolism. Trends Immunol 39(6):489–502
Franco F, Jaccard A, Romero P, Yu YR, Ho PC (2020) Metabolic and epigenetic regulation of T-cell exhaustion. Nat Metab 2(10):1001–1012
Fu Z, Zhang J (2022) Molecular hydrogen is a promising therapeutic agent for pulmonary disease. J Zhejiang Univ Sci B 23(2):102–122
Fulling C, Dinan TG, Cryan JF (2019) Gut microbe to brain signaling: what happens in vagus. Neuron 101(6):998–1002
Ge L, Qi J, Shao B, Ruan Z, Ren Y, Sui S, Wu X, Sun X, Liu S, Li S, Xu C, Song W (2022) Microbial hydrogen economy alleviates colitis by reprogramming colonocyte metabolism and reinforcing intestinal barrier. Gut Microbes 14(1):2013764
Greening C, Biswas A, Carere CR, Jackson CJ, Taylor MC, Stott MB, Cook GM, Morales SE (2016) Genomic and metagenomic surveys of hydrogenase distribution indicate H2 is a widely utilised energy source for microbial growth and survival. ISME J 10(3):761–777
Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA (2019) The microbiome, cancer, and cancer therapy. Nat Med 25(3):377–388
Higashimura Y, Baba Y, Inoue R, Takagi T, Uchiyama K, Mizushima K, Hirai Y, Ushiroda C, Tanaka Y, Naito Y (2018) Effects of molecular hydrogen-dissolved alkaline electrolyzed water on intestinal environment in mice. Med Gas Res 8(1):6–11
Hirano SI, Yamamoto H, Ichikawa Y, Sato B, Takefuji Y, Satoh F (2021a) Molecular hydrogen as a novel antitumor agent: possible mechanisms underlying gene expression. Int J Mol Sci 22(16):8724
Hirano SI, Aoki Y, Li XK, Ichimaru N, Takahara S, Takefuji Y (2021b) Protective effects of hydrogen gas inhalation on radiation-induced bone marrow damage in cancer patients: a retrospective observational study. Med Gas Res 11(3):104–109
Holmstrom KM, Finkel T (2014) Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol 15(6):411–421
Hornsveld M, Dansen TB (2016) The hallmarks of cancer from a redox perspective. Antioxid Redox Signal 25(6):300–325
Hsiao YF, Cheng SB, Lai CY, Liu HT, Huang SC, Huang YC (2021) The prognostic role of glutathione and its related antioxidant enzymes in the recurrence of hepatocellular carcinoma. Nutrients 13(11):4071
Iio A, Ito M, Itoh T, Terazawa R, Fujita Y, Nozawa Y, Ohsawa I, Ohno K, Ito M (2013) Molecular hydrogen attenuates fatty acid uptake and lipid accumulation through downregulating CD36 expression in HepG2 cells. Med Gas Res 3(1):6
Iketani M, Ohshiro J, Urushibara T, Takahashi M, Arai T, Kawaguchi H, Ohsawa I (2017) Preadministration of hydrogen-rich water protects against lipopolysaccharide-induced sepsis and attenuates liver injury. Shock 48(1):85–93
Ishikawa T, Shimada S, Fukai M, Kimura T, Umemoto K, Shibata K, Fujiyoshi M, Fujiyoshi S, Hayasaka T, Kawamura N, Kobayashi N, Shimamura T, Taketomi A (2018) Post-reperfusion hydrogen gas treatment ameliorates ischemia reperfusion injury in rat livers from donors after cardiac death: a preliminary study. Surg Today 48(12):1081–1088
Ismail T, Kim Y, Lee H, Lee DS, Lee HS (2019) Interplay between mitochondrial peroxiredoxins and ROS in cancer development and progression. Int J Mol Sci 20(18):4407
Ito M, Hirayama M, Yamai K, Goto S, Ito M, Ichihara M, Ohno K (2012) Drinking hydrogen water and intermittent hydrogen gas exposure, but not lactulose or continuous hydrogen gas exposure, prevent 6-hydorxydopamine-induced Parkinson’s disease in rats. Med Gas Res 2(1):15
Jena NR (2012) DNA damage by reactive species: mechanisms, mutation and repair. J Biosci 37(3):503–517
Jiang F, Du C, Jiang W, Wang L, Du SK (2020) The preparation, formation, fermentability, and applications of resistant starch. Int J Biol Macromol 150:1155–1161
Jing YZ, Li SJ, Sun ZJ (2021) Gas and gas-generating nanoplatforms in cancer therapy. J Mater Chem B 9(41):8541–8557
Kajiyama S, Hasegawa G, Asano M, Hosoda H, Fukui M, Nakamura N, Kitawaki J, Imai S, Nakano K, Ohta M, Adachi T, Obayashi H, Yoshikawa T (2008) Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr Res 28(3):137–143
Kalantar-Zadeh K, Berean KJ, Burgell RE, Muir JG, Gibson PR (2019) Intestinal gases: influence on gut disorders and the role of dietary manipulations. Nat Rev Gastroenterol Hepatol 16(12):733–747
Kamimura N, Nishimaki K, Ohsawa I, Ohta S (2011) Molecular hydrogen improves obesity and diabetes by inducing hepatic FGF21 and stimulating energy metabolism in db/db mice. Obesity (silver Spring) 19(7):1396–1403
Kawai D, Takaki A, Nakatsuka A, Wada J, Tamaki N, Yasunaka T, Koike K, Tsuzaki R, Matsumoto K, Miyake Y, Shiraha H, Morita M, Makino H, Yamamoto K (2012) Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice. Hepatology 56(3):912–921
Kikkawa YS, Nakagawa T, Taniguchi M, Ito J (2014) Hydrogen protects auditory hair cells from cisplatin-induced free radicals. Neurosci Lett 579:125–129
Kong Q, Wang B, Tian P, Li X, Zhao J, Zhang H, Chen W, Wang G (2021) Daily intake of Lactobacillus alleviates autistic-like behaviors by ameliorating the 5-hydroxytryptamine metabolic disorder in VPA-treated rats during weaning and sexual maturation. Food Funct 12(6):2591–2604
Lai Z, Shan W, Li J, Min J, Zeng X, Zuo Z (2021) Appropriate exercise level attenuates gut dysbiosis and valeric acid increase to improve neuroplasticity and cognitive function after surgery in mice. Mol Psychiatry 26(12):7167–7187
Lee SY, Lee DY, Kang JH, Kim JH, Jeong JW, Kim HW, Oh DH, Yoon SH, Hur SJ (2022) Relationship between gut microbiota and colorectal cancer: probiotics as a potential strategy for prevention. Food Res Int 156:111327
Li J, Wang C, Zhang JH, Cai JM, Cao YP, Sun XJ (2010) Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer’s disease by reduction of oxidative stress. Brain Res 1328:152–161
Li S, Liao R, Sheng X, Luo X, Zhang X, Wen X, Zhou J, Peng K (2019) Hydrogen gas in cancer treatment. Front Oncol 9:696
Liao Z, Chua D, Tan NS (2019) Reactive oxygen species: a volatile driver of field cancerization and metastasis. Mol Cancer 18(1):65
Matzner P, Sandbank E, Neeman E, Zmora O, Gottumukkala V, Ben-Eliyahu S (2020) Harnessing cancer immunotherapy during the unexploited immediate perioperative period. Nat Rev Clin Oncol 17(5):313–326
McCarty MF (2015) Potential ghrelin-mediated benefits and risks of hydrogen water. Med Hypotheses 84(4):350–355
Mego M, Accarino A, Tzortzis G, Vulevic J, Gibson G, Guarner F, Azpiroz F (2017) Colonic gas homeostasis: mechanisms of adaptation following HOST-G904 galactooligosaccharide use in humans. Neurogastroenterol Motil 29(9):e13080
Meng X, Chen H, Wang G, Yu Y, Xie K (2015) Hydrogen-rich saline attenuates chemotherapy-induced ovarian injury via regulation of oxidative stress. Exp Ther Med 10(6):2277–2282
Meng J, Lv Z, Zhang Y, Wang Y, Qiao X, Sun C, Chen Y, Guo M, Han W, Ye A, Xie T, Chu B, Shi C, Yang S, Chen C (2021) Precision redox: the key for antioxidant pharmacology. Antioxid Redox Signal 34(14):1069–1082
Mo XY, Li XM, She CS, Lu XQ, Xiao CG, Wang SH, Huang GQ (2019) Hydrogen-rich saline protects rat from oxygen glucose deprivation and reperusion-induced apoptosis through VDAC1 via Bcl-2. Brain Res 1706:110–115
Najjar YG, Menk AV, Sander C, Rao U, Karunamurthy A, Bhatia R, Zhai S, Kirkwood JM, Delgoffe GM (2019) Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma. JCI Insight 4(5):e124989
Nakashima-Kamimura N, Mori T, Ohsawa I, Asoh S, Ohta S (2009) Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice. Cancer Chemother Pharmacol 64(4):753–761
Ngowi EE, Afzal A, Sarfraz M, Khattak S, Zaman SU, Khan NH, Li T, Jiang QY, Zhang X, Duan SF, Ji XY, Wu DD (2021) Role of hydrogen sulfide donors in cancer development and progression. Int J Biol Sci 17(1):73–88
Nguyen LH, Ma W, Wang DD, Cao Y, Mallick H, Gerbaba TK, Lloyd-Price J, Abu-Ali G, Hall AB, Sikavi D, Drew DA, Mehta RS, Arze C, Joshi AD, Yan Y, Branck T, DuLong C, Ivey KL, Ogino S, Rimm EB, Song M, Garrett WS, Izard J, Huttenhower C, Chan AT (2020) Association between sulfur-metabolizing bacterial communities in stool and risk of distal colorectal cancer in men. Gastroenterology 158(5):1313–1325
Nishimura N, Tanabe H, Adachi M, Yamamoto T, Fukushima M (2013) Colonic hydrogen generated from fructan diffuses into the abdominal cavity and reduces adipose mRNA abundance of cytokines in rats. J Nutr 143(12):1943–1949
Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S (2007) Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 13(6):688–694
Oliveira C, Benfeito S, Fernandes C, Cagide F, Silva T, Borges F (2018) NO and HNO donors, nitrones, and nitroxides: past, present, and future. Med Res Rev 38(4):1159–1187
Ono H, Nishijima Y, Ohta S, Sakamoto M, Kinone K, Horikosi T, Tamaki M, Takeshita H, Futatuki T, Ohishi W, Ishiguro T, Okamoto S, Ishii S, Takanami H (2017) Hydrogen gas inhalation treatment in acute cerebral infarction: a randomized controlled clinical study on safety and neuroprotection. J Stroke Cerebrovasc Dis 26(11):2587–2594
Ostojic SM (2021) Does drinking water rich in hydrogen gas revive brain hypometabolism in neurodegeneration by SCFAs upregulation? Eur J Clin Nutr 75(1):212–213
Perlamutrov YN, Olhovskaya KB, Zakirova SA (2016) Double-blind controlled randomised study of lactulose and lignin hydrolysed combination in complex therapy of atopic dermatitis. Microb Ecol Health Dis 27:30418
Peters JW, Schut GJ, Boyd ES, Mulder DW, Shepard EM, Broderick JB, King PW, Adams MW (2015) [FeFe]- and [NiFe]-hydrogenase diversity, mechanism, and maturation. Biochim Biophys Acta 1853(6):1350–1369
Prieto I, Montemuino S, Luna J, de Torres MV, Amaya E (2017) The role of immunonutritional support in cancer treatment: current evidence. Clin Nutr 36(6):1457–1464
Qiu X, Ye Q, Sun M, Wang L, Tan Y, Wu G (2020) Saturated hydrogen improves lipid metabolism disorders and dysbacteriosis induced by a high-fat diet. Exp Biol Med (maywood) 245(6):512–521
Rose P, Moore PK, Whiteman M, Kirk C, Zhu YZ (2021) Diet and hydrogen sulfide production in mammals. Antioxid Redox Signal 34(17):1378–1393
Runtuwene J, Amitani H, Amitani M, Asakawa A, Cheng KC, Inui A (2015) Hydrogen-water enhances 5-fluorouracil-induced inhibition of colon cancer. PeerJ 3:e859
Sano M, Suzuki M, Homma K, Hayashida K, Tamura T, Matsuoka T, Katsumata Y, Onuki S, Sasaki J (2018) Promising novel therapy with hydrogen gas for emergency and critical care medicine. Acute Med Surg 5(2):113–118
Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo MO (2014) Antioxidants accelerate lung cancer progression in mice. Sci Transl Med 6(221):221ra15
Scharping NE, Menk AV, Moreci RS, Whetstone RD, Dadey RE, Watkins SC, Ferris RL, Delgoffe GM (2016) The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity 45(2):374–388
Scharping NE, Rivadeneira DB, Menk AV, Vignali PDA, Ford BR, Rittenhouse NL, Peralta R, Wang Y, Wang Y, DePeaux K, Poholek AC, Delgoffe GM (2021) Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. Nat Immunol 22(2):205–215
Seckler F, Doussot A, Colpart P, Turco C, Calame P, Aubin F, Algros MP, Borg C, Nardin C, Heyd B (2020) Preoperative immunotherapy for resectable hepatocellular carcinoma: toward a paradigm shift? J Hepatol 73(6):1588–1590
Sena LA, Chandel NS (2012) Physiological roles of mitochondrial reactive oxygen species. Mol Cell 48(2):158–167
Shi Q, Chen C, Deng W-H, Wang P, Zuo T, Zhao L, Yu J, Zhao K-L, Mei F-C, Li C, Wang G-R, Wang W-X (2016) Hydrogen-rich saline attenuates acute hepatic injury in acute necrotizing pancreatitis by inhibiting inflammation and apoptosis, involving JNK and p38 mitogen-activated protein kinase–dependent reactive oxygen species. Pancreas 45(10):1424–1431
Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7–30
Siska PJ, Beckermann KE, Mason FM, Andrejeva G, Greenplate AR, Sendor AB, Chiang YJ, Corona AL, Gemta LF, Vincent BG, Wang RC, Kim B, Hong J, Chen CL, Bullock TN, Irish JM, Rathmell WK, Rathmell JC (2017) Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma. JCI Insight 2(12):e93411
Slezak J, Kura B, LeBaron TW, Singal PK, Buday J, Barancik M (2021) Oxidative stress and pathways of molecular hydrogen effects in medicine. Curr Pharm Des 27(5):610–625
Song M, Chan AT, Sun J (2020) Influence of the gut microbiome, diet, and environment on risk of colorectal cancer. Gastroenterology 158(2):322–340
Sun R, Liu X, Li G, Wang H, Luo Y, Huang G, Wang X, Zeng G, Liu Z, Wu S (2020) Photoactivated H2 nanogenerator for enhanced chemotherapy of bladder cancer. ACS Nano 14(7):8135–8148
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249
Suzuki A, Ito M, Hamaguchi T, Mori H, Takeda Y, Baba R, Watanabe T, Kurokawa K, Asakawa S, Hirayama M, Ohno K (2018) Quantification of hydrogen production by intestinal bacteria that are specifically dysregulated in Parkinson’s disease. PLoS ONE 13(12):e0208313
Svetikiene M, Ringaitiene D, Vezeliene J, Isajevas V, Trybe D, Vicka V, Malickaite R, Jurgauskiene L, Norkuniene J, Serpytis M, Sipylaite J (2021) The efficacy of early postoperative enteral immunonutrition on T-lymphocyte count: a randomised control study in low-risk cardiac surgery patients. Clin Nutr 40(2):372–379
Tao G, Song G, Qin S (2019) Molecular hydrogen: current knowledge on mechanism in alleviating free radical damage and diseases. Acta Biochim Biophys Sin (shanghai) 51(12):1189–1197
Tien Vo TT, Vo QC, Tuan VP, Wee Y, Cheng H-C, Lee IT (2021) The potentials of carbon monoxide-releasing molecules in cancer treatment: an outlook from ROS biology and medicine. Redox Biol 46:102124
Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, Blanchard C, Junt T, Nicod LP, Harris NL, Marsland BJ (2014) Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20(2):159–166
Van Acker HH, Ma S, Scolaro T, Kaech SM, Mazzone M (2021) How metabolism bridles cytotoxic CD8(+) T cells through epigenetic modifications. Trends Immunol 42(5):401–417
Vasan N, Baselga J, Hyman DM (2019) A view on drug resistance in cancer. Nature 575(7782):299–309
Vaughan A, Frazer ZA, Hansbro PM, Yang IA (2019) COPD and the gut-lung axis: the therapeutic potential of fibre. J Thorac Dis 11(Suppl 17):S2173–S2180
Wang D, Wang L, Zhang Y, Zhao Y, Chen G (2018) Hydrogen gas inhibits lung cancer progression through targeting SMC3. Biomed Pharmacother 104:788–797
Wang Z, Wang G, Xie K (2020) Prospects of molecular hydrogen in perioperative neuroprotection from basic research to clinical application. Curr Opin Anaesthesiol 33(5):655–660
Wen YF, Chen MX, Yin G, Lin R, Zhong YJ, Dong QQ, Wong HM (2021) The global, regional, and national burden of cancer among adolescents and young adults in 204 countries and territories, 1990–2019: a population-based study. J Hematol Oncol 14(1):89
Wojtovich AP, Berry BJ, Galkin A (2019) Redox signaling through compartmentalization of reactive oxygen species: implications for health and disease. Antioxid Redox Signal 31(9):591–593
Wu MJ, Chen M, Sang S, Hou LL, Tian ML, Li K, Lv FQ (2017) Protective effects of hydrogen rich water on the intestinal ischemia/reperfusion injury due to intestinal intussusception in a rat model. Med Gas Res 7(2):101–106
Wu Y, Yuan M, Song J, Chen X, Yang H (2019) Hydrogen gas from inflammation treatment to cancer therapy. ACS Nano 13(8):8505–8511
Wu Y, Su L, Yuan M, Chen T, Ye J, Jiang Y, Song J, Yang H (2021) In vivo X-ray triggered catalysis of H2 generation for cancer synergistic gas radiotherapy. Angew Chem Int Ed Engl 60(23):12868–12875
Xiao HW, Li Y, Luo D, Dong JL, Zhou LX, Zhao SY, Zheng QS, Wang HC, Cui M, Fan SJ (2018) Hydrogen-water ameliorates radiation-induced gastrointestinal toxicity via MyD88’s effects on the gut microbiota. Exp Mol Med 50(1):e433
Xie K, Zhang Y, Wang Y, Meng X, Wang Y, Yu Y, Chen H (2020) Hydrogen attenuates sepsis-associated encephalopathy by NRF2 mediated NLRP3 pathway inactivation. Inflamm Res 69(7):697–710
Xu C, Chen YP, Du XJ, Liu JQ, Huang CL, Chen L, Zhou GQ, Li WF, Mao YP, Hsu C, Liu Q, Lin AH, Tang LL, Sun Y, Ma J (2018) Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis. BMJ 363:k4226
Yang Y, Li B, Liu C, Chuai Y, Lei J, Gao F, Cui J, Sun D, Cheng Y, Zhou C, Cai J (2012) Hydrogen-rich saline protects immunocytes from radiation-induced apoptosis. Med Sci Monit 18(4):BR144–BR148
Yip W, Hughes MR, Li Y, Cait A, Hirst M, Mohn WW, McNagny KM (2021) Butyrate shapes immune cell fate and function in allergic asthma. Front Immunol 12:628453
Yu Y, Yang Y, Yang M, Wang C, Xie K, Yu Y (2019) Hydrogen gas reduces HMGB1 release in lung tissues of septic mice in an Nrf2/HO-1-dependent pathway. Int Immunopharmacol 69:11–18
Zhai X, Chen X, Shi J, Shi D, Ye Z, Liu W, Li M, Wang Q, Kang Z, Bi H, Sun X (2013) Lactulose ameliorates cerebral ischemia-reperfusion injury in rats by inducing hydrogen by activating Nrf2 expression. Free Radic Biol Med 65:731–741
Zhai S, Zhu L, Qin S, Li L (2018) Effect of lactulose intervention on gut microbiota and short chain fatty acid composition of C57BL/6J mice. Microbiologyopen 7(6):e00612
Zhang J, Wang X, Vikash V, Ye Q, Wu D, Liu Y, Dong W (2016) ROS and ROS-mediated cellular signaling. Oxid Med Cell Longev 2016:4350965
Zhang B, Wang F, Zhou H, Gao D, Yuan Z, Wu C, Zhang X (2019) Polymer dots compartmentalized in liposomes as a photocatalyst for in situ hydrogen therapy. Angew Chem Int Ed Engl 58(9):2744–2748
Zhang Y, Liu H, Xu J, Zheng S, Zhou L (2021) Hydrogen gas: a novel type of antioxidant in modulating sexual organs homeostasis. Oxid Med Cell Longev 2021:8844346
Zhao L, Zhou C, Zhang J, Gao F, Li B, Chuai Y, Liu C, Cai J (2011) Hydrogen protects mice from radiation induced thymic lymphoma in BALB/c mice. Int J Biol Sci 7(3):297–300
Zhou P, Lin B, Wang P, Pan T, Wang S, Chen W, Cheng S, Liu S (2019) The healing effect of hydrogen-rich water on acute radiation-induced skin injury in rats. J Radiat Res 60(1):17–22
Acknowledgements
This research was supported by the National Key Research and Development Program of China (NO. 2020YFC2008400), the National Natural Science Foundation of China (NO.81873948), the Clinical Research Plan of SHDC (NO. SHDC2020CR1005A). All figures were created with BioRender.com and have publication and licensing rights.
Funding
No dedicated funding was obtained to write this Review Article.
Author information
Authors and Affiliations
Contributions
Miao CH conceived the idea and was responsible for the overall direction. Chen WK wrote the article and was responsible for the overall direction and planning. Zhou WC and Zhang J prepared figures and contributed to the writing of the article.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhou, W., Zhang, J., Chen, W. et al. Prospects of molecular hydrogen in cancer prevention and treatment. J Cancer Res Clin Oncol 150, 170 (2024). https://doi.org/10.1007/s00432-024-05685-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00432-024-05685-7